Table 1.
miRNAs and their targets in aerobic glycolysis in three major gynecological tumors
| Glycolytic protein | MiRNAs | Role | Expression | Mechanism | Type of cancer | References | |
|---|---|---|---|---|---|---|---|
| HK2 | miR-145, miR-148a, miR-497 | CSCs, chemotherapy resistance | down | / | CC | 18 | |
| miR-9-5p | Tumor suppressor | down | AKT/mTOR, p53 | CC | 17 | ||
| miR-143-3p | - | down | Myc | CC | 70 | ||
| circCDKN2B-AS1 | Tumor suppressor | up | IMP3 | CC | 71 | ||
| LDHA | miR-34a | chemotherapy sensitivity | down | lncRNA NEAT1 | CC | 23 | |
| PDK1 | miR-126-3p | Tumor suppressor | down | Bcl-xL, Bax, caspase 3/7 | CC | 28 | |
| miR-155-5p | autophagy | down | LC3, P62 | CC | 29 | ||
| PDK4 | miR‐103a‐3p | Tumor promoter | down | ncRNA LINC00662 | CC | 30 | |
| miR-16-5p | chemotherapy resistance | down | / | CC | 31 | ||
| PKM2 | miR-let-7a | Tumor suppressor | down | / | CC | 72 | |
| IDH2 | miR-124-5p | Tumor promoter | down | HIF-1α | CC | 44 | |
| HK2 | miR-455, miR-181a | EMT | down | DLEU2, EZH2 | EC | 55 | |
| HK2 | miR-603 | Tumor suppressor | down | 20(S)-Rg3, DNMT3A | OC | 73 | |
| miR‐145 | / | down | DNMT3A | OC | 74 | ||
| miR-1244 | Tumor promoter | down | lncRNA LINC00504 | OC | 75 | ||
| LDHA | miR-383 | Tumor suppressor | down | / | OC | 76 | |
| PDK4 | miR-107 | Tumor promoter | down | lncRNA AFAP1-AS1 | OC | 77 | |
| PKM2 | miR-324-5p | Tumor suppressor | down | 20(S)-Rg3, H19 | OC | 78 | |
| miR-1244 | Tumor promoter | down | lncRNA LINC00504 | OC | 75 | ||
| PDK1 | miR-1244 | Tumor promoter | down | lncRNA LINC00504 | OC | 75 | |
| CDH1 | miR-106a | Tumor promoter | down | circ-ITCH | OC | 79 | |
| circ-PGAM1 | miR-542-3p | Tumor promoter | down | CDC5L, PEAK1 | OC | 80 | |
| GADPH | miR-125b | Tumor promoter | down | STAT3 | OC | 81 | |
| GLUT-1 | miR-1204 | Tumor promoter | up | / | OC | 82 | |